Harte Hanks (HHS) director discloses 27,861 RSU grant and holdings

Rhea-AI Filing Summary

Harte Hanks Inc. director Bradley Radoff reported receiving 27,861 shares of common stock as restricted stock units (RSUs) on 12/09/2025 at $3.23 per share. These RSUs will vest 100% on the first anniversary of the grant date.

After this grant, he beneficially owns 27,861 RSUs held indirectly, 391,399 shares of Harte Hanks common stock directly, 20,000 shares held indirectly in an IRA, and 12,048 additional shares held directly that vested 100% on 5/23/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Radoff Bradley Louis

(Last) (First) (Middle)

1 EXECUTIVE DR, SUITE 303

(Street)

CHELMSFORD MA 01824

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTE HANKS INC [ HHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		A		27,861	A	$3.23	27,861(1)	I	RSU shares held by Harte Hanks, granted to the participant but not yet vested
Common Stock								391,399	D
Common Stock								20,000(2)	I	Common stock held in participant's IRA
Common Stock								12,048(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

2. Common stock held in participant's IRA

3. Shares vested 100% on 5/23/2025.

Remarks:

	/s/ Robert Wyman, Attorney-in-fact for Bradley Radoff	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Harte Hanks (HHS) disclose in this Form 4?

The Form 4 shows that director Bradley Radoff received a grant of 27,861 restricted stock unit (RSU) shares of Harte Hanks common stock on 12/09/2025 at $3.23 per share.

How many RSUs did the Harte Hanks (HHS) director receive and when do they vest?

Bradley Radoff was granted 27,861 RSU shares on 12/09/2025. These RSUs will vest 100% on the first anniversary of the grant date.

How many Harte Hanks (HHS) shares does Bradley Radoff beneficially own after this transaction?

Following the reported grant, he beneficially owns 27,861 RSUs indirectly, 391,399 common shares directly, 20,000 common shares indirectly in an IRA, and 12,048 additional common shares directly.

What is Bradley Radoff’s relationship to Harte Hanks (HHS)?

Bradley Radoff is reported as a director of Harte Hanks Inc. on this Form 4.

What do the indirect holdings reported for Harte Hanks (HHS) represent?

The filing notes 27,861 RSU shares held indirectly as RSUs granted but not yet vested, and 20,000 common shares held indirectly in the participant's IRA.

When did the 12,048 Harte Hanks (HHS) shares reported as direct ownership vest?

The explanation states that 12,048 shares vested 100% on 5/23/2025, and they are reported as directly owned common stock.